English
Back
Download
Log in to access Online Inquiry
Back to the Top

Pretty nice!

$TScan Therapeutics (TCRX.US)$ TScan Therapeutics (NASDAQ:TCRX) reported quarterly losses of $(0.21) per share which beat the analyst consensus estimate of $(0.29) by 27.59 percent. This is a 73.08 percent increase over losses of $(0.78) per share from the same period last year. The company reported quarterly sales of $7.21 million which beat the analyst consensus estimate of $3.34 million by 115.90 percent. This is a 132.91 percent increase over sales of $3.10 million the same period last year.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
1
+0
2
Translate
Report
4008 Views
Comment
Sign in to post a comment
3643Followers
23Following
54KVisitors
Follow